₹ 108.55
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Parnax Lab Limited specializes in the production and commercialization of a variety of pharmaceutical and healthcare products. Their offerings span a diverse range of medicinal forms, including liquid preparations, topical applications like ointments, gels, and creams, as well as solid oral dosages such as tablets and capsules. The enterprise was established on August 3, 1982, and operates from its corporate headquarters located in Mumbai, India.
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITD
Data is available to registered users only